News & Analysis on Clinical Trial Services & Contract Research And Development
The world's largest drug firm, Pfizer, warned that 2005 would be its "toughest year ever" as the pharmaceutical company detailed restructuring plans to save $4 billion (€3.1 billion) in costs every year as well as cushion the blow of losing...
The world's number one drug company, Pfizer, yesterday announced cost-cutting measures aimed at saving $4 billion (€3.1bn) by 2008, as it faces a raft of patent expirations on its top drugs and continued pressure on its painkiller Celebrex...
Huntingdon Life Sciences has announced the expansion of its pre-clinical pharmaceutical inhalation safety testing facility in the US, which aims to double capacity and meet the increasingly rigorous requirements demanded by the pharmaceutical industry.
Belgian chemicals company Solvay is planning to expand its production of sodium bicarbonate to improve supplies into the European market, reports Phil Taylor.
Two UK companies have joined forces to tackle the fast-growing contract synthesis market for peptide and protein drugs.
The Association of the British Pharmaceutical Industry has praised the latest report, acknowledging the importance of the UK pharmaceutical industry in "improving people's quality of life, reducing the need for surgical intervention and the length of...